A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid …
…, WJ Shergy, PS Hanrahan, MM Kraishi… - Annals of the …, 2004 - ard.bmj.com
Objective: To assess the efficacy and safety of 100 mg daily anakinra (Kineret), a recombinant
form of the naturally occurring interleukin 1 receptor antagonist, plus methotrexate (MTX) …
form of the naturally occurring interleukin 1 receptor antagonist, plus methotrexate (MTX) …
CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides
…, A Fifi-Mah, M Goulet, N Khalidi, MM Khraishi… - The Journal of …, 2016 - jrheum.org
Objective. The Canadian Vasculitis research network (CanVasc) is composed of physicians
from different medical specialties and researchers with expertise in vasculitis. One of its aims …
from different medical specialties and researchers with expertise in vasculitis. One of its aims …
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
PJ Mease, DD Gladman, KA Papp, MM Khraishi… - Journal of the American …, 2013 - Elsevier
… Dr Khraishi received unrestricted educational grants from Pfizer Canada. Dr Thaçi received
honoraria for consultations or speaking engagements from Abbott, Amgen, Astellas, Biogen …
honoraria for consultations or speaking engagements from Abbott, Amgen, Astellas, Biogen …
Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics
…, DD Gladman, P Helliwell, MM Khraishi… - Journal of the American …, 2014 - Elsevier
… Dr Khraishi received unrestricted educational grants from Pfizer Canada. Ms Fuiman, Dr
Bananis, and Dr Alvarez are employees of Pfizer Inc and owners of Pfizer Inc stock. …
Bananis, and Dr Alvarez are employees of Pfizer Inc and owners of Pfizer Inc stock. …
The role of anti-malarials in rheumatoid arthritis–the American experience
MM Khraishi, G Singh - Lupus, 1996 - journals.sagepub.com
Rheumatoid Arthritis (RA) is a chronic disease with significant morbidity and functional disability.
The traditional treatment for RA relied on the use of NSAIDs early in the disease course, …
The traditional treatment for RA relied on the use of NSAIDs early in the disease course, …
Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in …
…, P Rahman, YM Tobin, MM Khraishi… - The Journal of …, 2003 - jrheum.org
… with 10% fetal bovine serum, 2 mM glutamine, 100 µg/ml penicillin, 100 µg/ml streptomycin,
1 mM sodium pyruvate, and 1 mM MEM amino acids (Invitrogen Life Technologies, New York…
1 mM sodium pyruvate, and 1 mM MEM amino acids (Invitrogen Life Technologies, New York…
CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides–Executive summary
…, M Goulet, N Khalidi, MM Khraishi… - … Journal of Kidney …, 2015 - journals.sagepub.com
The Canadian Vasculitis research network (CanVasc) is composed of physicians from
different medical specialties, including rheumatology and nephrology and researchers with …
different medical specialties, including rheumatology and nephrology and researchers with …
HLA antigens in North American patients with Takayasu arteritis
MM Khraishi, DD Gladman, P Dagenais… - … : Official Journal of …, 1992 - Wiley Online Library
Objective. To determine the frequency of HLA class I and II antigens in Caucasian North
American patients with Takayasu arteritis (TA). Methods. Seventy‐three class I antigens and 13 …
American patients with Takayasu arteritis (TA). Methods. Seventy‐three class I antigens and 13 …
Treating psoriasis and psoriatic arthritis: position paper on applying the treat-to-target concept to Canadian daily practice
…, VC Ho, CH Hong, J Karsh, MM Khraishi… - The Journal of …, 2017 - jrheum.org
Objective. To develop preliminary treat-to-target (T2T) recommendations for psoriasis and
psoriatic arthritis (PsA) for Canadian daily practice. Methods. A task force composed of expert …
psoriatic arthritis (PsA) for Canadian daily practice. Methods. A task force composed of expert …
Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study design
…, M Zummer, WG Bensen, MM Kraishi - The Journal of …, 2011 - jrheum.org
Objective. Current clinical trial designs for pharmacologic interventions in rheumatoid arthritis
(RA) do not reflect the innovations in RA diagnosis, treatment, and care in countries where …
(RA) do not reflect the innovations in RA diagnosis, treatment, and care in countries where …